Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation
Open Access
- 20 February 2018
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2018, 1-11
Abstract
Numerous studies have examined the pathogenesis of osteoporosis. The causes of osteoporosis include endocrine factors, nutritional status, genetic factors, physical factors, and immune factors. Recent osteoimmunology studies demonstrated that the immune system and immune factors play important regulatory roles in the occurrence of osteoporosis, and people should pay more attention to the relationship between immunity and osteoporosis. Immune and bone cells are located in the bone marrow and share numerous regulatory molecules, signaling molecules, and transcription factors. Abnormal activation of the immune system alters the balance between osteoblasts and osteoclasts, which results in an imbalance of bone remodeling and osteoporosis. The incidence of osteoporosis is also increasing with the aging of China’s population, and traditional Chinese medicine has played a vital role in the prevention and treatment of osteoporosis for centuries. Chinese medicinal plants possess unique advantages in the regulation of the immune system and the relationships between osteoporosis and the immune system. In this review, we provide a general overview of Chinese medicinal plants in the prevention and treatment of osteoporosis, focusing on immunological aspects.Keywords
Funding Information
- National Natural Science Foundation of China (81373773, 81573845, 81673841, 81673844)
- National Natural Science Foundation of China (81373773, 81573845, 81673841, 81673844)
- National Natural Science Foundation of China (81373773, 81573845, 81673841, 81673844)
- National Natural Science Foundation of China (81373773, 81573845, 81673841, 81673844)
This publication has 130 references indexed in Scilit:
- Effect of Total Glycosides from Eucommia ulmoides Seed on Bone Microarchitecture in RatsPhytotherapy Research, 2011
- Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitisBiochemical and Biophysical Research Communications, 2010
- Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in ratsBone, 2009
- Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized miceJournal of Bone and Mineral Metabolism, 2009
- Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in ratsBiochemical and Biophysical Research Communications, 2008
- Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblastsEuropean Journal of Pharmacology, 2008
- Treg cells suppress osteoclast formation: A new link between the immune system and boneArthritis & Rheumatism, 2007
- Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP‐1Journal of Cellular Biochemistry, 2004
- Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenineInternational Journal of Immunopharmacology, 1994
- Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal miceInternational Journal of Immunopharmacology, 1990